OmniStar Financial Group’s Amedisys AMED Stock Holding History

OmniStar Financial Group’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-58	Closed	-$11K	–	119
2020 Q1	$11K	Buy	+58	New	+$10.3K	0.01%	220

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

OmniStar Financial Group's AMED Position: Q2 2020 in Review

OmniStar Financial Group sold out of Amedisys (AMED) in Q2 2020, closing a stake of 58 shares — an estimated $11K sold.

OmniStar Financial Group first reported a position in AMED in Q1 2020 and held it in 1 quarter. The position peaked at $11K in Q1 2020. 354 funds tracked by Wall St. Rank hold AMED as of Q2 2020.

OmniStar Financial Group reported no remaining Amedisys position as of Q2 2020 after selling out during the quarter.
OmniStar Financial Group sold 58 Amedisys shares in Q2 2020, an estimated $11K.
OmniStar Financial Group first reported a position in Amedisys in Q1 2020 and held it in 1 quarter.
OmniStar Financial Group's Amedisys position peaked at $11K in Q1 2020.
354 funds tracked by Wall St. Rank held Amedisys as of Q2 2020.

Based on OmniStar Financial Group's 13F filing for Q2 2020, filed 6 Jul 2020.